April 22, 2008 - Thoratec Corp. received FDA approval of its PMA (PreMarket Approval) application, allowing the use of its HeartMate II LVAS (Left Ventricular Assist System) as a bridge-to-transplantation (BTT) in patients suffering from advanced-stage heart failure.

April 22, 2008 - CardiacAssist has placed the TandemHeart System at five new medical centers, adding to its network of hospitals worldwide using the TandemHeart System in the Cath Lab and/or Operating Room for extracorporeal circulatory support.

The five new TandemHeart Centers of Excellence are:

- Advanced Perfusion Care, Pinehurst, NC
- Provena St. Joseph Medical Center, Joliet, IL
- Sarasota Memorial Hospital, Sarasota, FL
- St. Joseph Hospital of Atlanta, Atlanta, GA
- Temple University Hospital, Philadelphia, PA

April 22, 2008 - Defibtech's automated external defibrillators (AEDs) meet the American Heart Association's new hands-only CPR guidelines by providing voice prompts, the company said.

April 22, 2008 - Onset Medical received CE Mark Clearance to begin marketing its SoloPath transseptal access catheter in the European Union and select countries worldwide, offering a devie to allow percutaneous access to the chambers of the left heart and surrounding vasculature.

April 21, 2008 - The first patients were treated in a U.S. feasibility study using the Edwards Lifesciences SAPIEN transcatheter heart valve in addressing a congenital condition in which the valve between the right ventricle and the pulmonary artery is nonfunctional.

April 21, 2008 - Rapid cooling prior to reperfusion significantly reduced overall myocardial infarct size and protected the heart from other injury, according to a study by Cardium Therapeutics and its operating unit InnerCool Therapies, reported a study published online by BioMed Central (BMC) Cardiovascular Disorders (2008, 8:7, April 10, 2008).

April 16, 2008 - Boston Scientific Corp. will acquire CryoCor, Inc. and pay a cash purchase price of $1.35 per share of CryoCor, or approximately $17.6 million, as Boston Scientific pursues therapeutic solutions for atrial fibrillation (Afib).

April 21, 2008 - Angiotech Pharmaceuticals Inc. said last week it received 510(k) clearance from the FDA to market its 5-Fluorouracil (5-FU) coated central venous catheter (CVC).

The 5-FU CVC is the first drug-eluting medical device to be researched and developed completely in-house by Angiotech's research and development department. The company said it will be stepping stone for development of other implantable devices that utilize the same proprietary anti-infective technology.

April 18, 2008 - Boston Scientific Corpo. has received approval for the sale of its TAXUS Liberte paclitaxel-eluting coronary stent system in Canada, which it plans to launch the product immediately in Canada.

The Company reported that Health Canada's Therapeutic Products Directorate (TPD), the authority that regulates pharmaceutical drugs and medical devices, has approved its use.

ViTALConnect software is a Web-enabled medical tool that allows physicians to use PCs or notebook computers to access interactive 2D, 3D and 4D advanced visualization. ViTALConnect software offers users access that is critical in today’s hospital environment. This solution enables users to review studies and perform advanced analysis from any where at any time.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now